![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1875-533x|12|20|2317-2342
ISSN: 0929-8673
Source: Current Medicinal Chemistry, Vol.12, Iss.20, 2005-09, pp. : 2317-2342
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The Development of Novel HCV NS3-4A Protease Inhibitors
Anti-Infective Agents, Vol. 11, Iss. 2, 2013-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
QSAR and Docking Studies of HCV NS3 Serine Protease Inhibitors
Medicinal Chemistry, Vol. 9, Iss. 6, 2013-09 ,pp. :